Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/27/2003US20030219443 Mycobacterium tuberculosis superoxide dismutase
11/27/2003US20030219442 Human monoclonal antibodies to influenza M2 protein and methods of making and using same
11/27/2003US20030219439 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders
11/27/2003US20030219438 Human antibodies that bind human TNFalpha
11/27/2003US20030219437 Administering antibodies used as antagonists to CD antigen ligands on the cells, for prophylaxis of cardiovascular, gastrointestinal or urogenital disorders
11/27/2003US20030219435 Method of reducing an immune response to a recombinant virus
11/27/2003US20030219433 Anti-CD20 antibodies and fusion proteins thereof and methods of use
11/27/2003US20030219428 Deoxyribonuclease formed by genetic engineering, used for prophylaxis respiratory system disorders, lupus erythematosus and/or genetic disorders
11/27/2003US20030219426 Endostatins used as antiproliferative agents or angiogenesis inhibitors for prophylaxis of tumors, or as contraceptives
11/27/2003US20030219422 Polyucleotides having hammerhead motif used for detection and analysis; biosensors
11/27/2003US20030219419 Alteration of cell membrane for new functions
11/27/2003US20030219418 Diabetic treatment by regenerating pancreas cells, genetic engineered animal embryonic pancreatic cells from different species, inserting embryonic cells into the kidney capsule of non-obese diabetic/ severe combined immunodeficiency animal
11/27/2003US20030219415 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions
11/27/2003US20030219414 A gene therapy transfecting a host cell, promoting gene transcription and translation, encoding beta-glucuronidase, sustained expression of the defective or missing enzyme
11/27/2003US20030219413 Method for overexpression of zwitterionic polysaccharides
11/27/2003US20030219412 Somatic gene therapy to suppress secondary cataract formation following eye surgery
11/27/2003US20030219411 Modulators of the function of FAS receptors and other proteins
11/27/2003US20030219410 Adenoviral vectors for modulating the cellular activities associated to PODs
11/27/2003US20030219409 Eukaryotic gene expression cassette and uses thereof
11/27/2003US20030219408 Methods of making pharmaceutical compositions with minicells
11/27/2003US20030219407 A genetic engineered DNA for treating or preventing a viral infections
11/27/2003US20030219403 Compositions and methods of tolerizing a primate to an antigen
11/27/2003US20030219402 Drug delivery of a fusion protein comprising plurality of component molecules linked with a linker, containing an enzyme cleavage site to be cleaved by an enzyme in a treated subject
11/27/2003US20030219385 Contrast agents for magnetic resonance imaging and methods related thereto
11/27/2003US20030219382 Cancer-linked gene as target for chemotherapy
11/27/2003US20030219381 Animal model for infection by an apicomplexan parasite
11/27/2003US20030219376 Progression elevated Gene-3 and uses thereof
11/27/2003CA2830619A1 Glucan-based vaccines
11/27/2003CA2812019A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2752143A1 Delivery of nucleic acid-like compounds
11/27/2003CA2524892A1 A purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof
11/27/2003CA2486913A1 Process for producing protein in cell-free protein synthesis system using thioredoxin fused protein expression vector
11/27/2003CA2486583A1 Marker molecules associated with lung tumors
11/27/2003CA2486529A1 Novel phospholipases and uses thereof
11/27/2003CA2486450A1 Chimaeric human papillomavirus 16 l1 virus-like particles and method for preparing the particles
11/27/2003CA2486112A1 Allergen mutants
11/27/2003CA2486028A1 Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pancreatic ductal carcinoma using pancreatic ductal carcinoma-specific gene that is identified by the method, and method of screening pharmaceutical candidate compound for treating or preventing pancreatic ductal carcinoma
11/27/2003CA2485969A1 Carotene synthase gene and uses therefor
11/27/2003CA2485847A1 Glucan-based vaccines
11/27/2003CA2485453A1 Polypeptide antigen inducing hiv neutralizing antibodies
11/27/2003CA2484955A1 Use of the repressor glxr for the synthesis of lysine in corynebacterium glutamicum
11/27/2003CA2484744A1 Molecular identification of aspergillus species
11/27/2003CA2484655A1 Transgenic ungulates capable of human antibody production
11/27/2003CA2484295A1 Attenuation of metapneumovirus
11/27/2003CA2483936A1 A method for identifying protein-protein interactions
11/27/2003CA2483712A1 Use of modified novirhabdoviruses to obtain vaccines
11/27/2003CA2483694A1 Automated system for isolating, amplifying and detecting a target nucleic acid sequence
11/27/2003CA2483692A1 Constitutively translocating cell line
11/27/2003CA2483640A1 Fusion protein of hiv regulatory/accessory proteins
11/27/2003CA2481799A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2481783A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
11/26/2003EP1365248A2 Spotting pin, spotting device and method for spotting biomolecules
11/26/2003EP1365246A1 Diagnostics and therapeutics for diseases associated with neuromedin U2 receptor (NMU2)
11/26/2003EP1365243A1 Immunoassay method/equipment, biological component measurable toilet, anti-albumin monoclonal antibody, cell strain producing the same, and albumin detection kit
11/26/2003EP1365034A2 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
11/26/2003EP1365032A1 Marker molecules associated with lung tumors
11/26/2003EP1365028A1 Method for expression of PDGF or IGF proteins in yeast
11/26/2003EP1365026A1 Dna encoding l-ribose isomerae and use thereof
11/26/2003EP1365025A1 Agarase and gene thereof
11/26/2003EP1365024A1 Traf3-binding b cell-specific receptor
11/26/2003EP1365021A1 Method of transferring selected molecules
11/26/2003EP1365020A1 Crystal structure and mutants of interleukin-1beta converting enzyme
11/26/2003EP1365016A2 Process abd apparatus to transfer medical actif compounds into cells
11/26/2003EP1364969A2 Human tissue factor related DNA segments, polypeptides and antibodies
11/26/2003EP1364966A2 Production of recombinant human epidermal growth factor in plants
11/26/2003EP1364965A1 Slit1 and MEGF4 isoforms and uses thereof
11/26/2003EP1364963A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof
11/26/2003EP1364702A2 Process for producing array plate for biomolecules having hydrophilic and hydrophobic regions
11/26/2003EP1364657A1 Remedies for tumor in hematopoietic organs
11/26/2003EP1364655A1 Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma
11/26/2003EP1364578A1 Schizophrenia-like mental disease model animal, method of constructing the same and use thereof
11/26/2003EP1364212A2 Three hybrid assay system
11/26/2003EP1364206A2 Rapid method for screening compounds for in vivo activity
11/26/2003EP1364205A1 Production of a monoclonal antibody by a transgenic avian
11/26/2003EP1364201A1 Ligand sensor devices and uses thereof
11/26/2003EP1364071A2 Novel method for analysing phenotypic characteristics of human immunodeficiency virus (hiv)
11/26/2003EP1364069A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes
11/26/2003EP1364066A2 Method for identifying functional nucleic acids
11/26/2003EP1364065A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof
11/26/2003EP1364064A2 Method for rapid detection and identification of bioagents
11/26/2003EP1364062A2 Diagnostic test for the detection of chromosomal abnormalities in a fetus
11/26/2003EP1364060A2 Polymorphisms in the zf9 gene linked to a predisposition for the development of inappropriate scarring or fibrosis
11/26/2003EP1364059A1 Methods for analysis of rna
11/26/2003EP1364058A2 Method for maldi-tof-ms analysis and/or sequencing of oligonucleotides
11/26/2003EP1364057A2 Ligand detection method
11/26/2003EP1364055A2 Solubility reporter gene constructs
11/26/2003EP1364054A2 Method of determining a chemotherapeutic regimen based on ercc1 expression
11/26/2003EP1364053A2 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
11/26/2003EP1364052A2 High throughput or capillary-based screening for a bioactivity or biomolecule
11/26/2003EP1364051A2 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure
11/26/2003EP1364049A2 Molecular toxicology modeling
11/26/2003EP1364048A2 Method of performing subtractive hybridization
11/26/2003EP1364046A2 Methods for genetic analysis of dna to detect sequence variances
11/26/2003EP1364043A1 Methods and kits for identifying scavengers of reactive oxygen species (ros)
11/26/2003EP1364038A2 Adenovirus particles with mutagenized fiber proteins
11/26/2003EP1364037A2 Methods and compositions useful for stimulating an immune response
11/26/2003EP1364036A2 Stress resistance as a selectable marker for transgenic plants
11/26/2003EP1364035A1 Vectors capable of imparting herbicide resistance and viral cross protection and methods
11/26/2003EP1364034A1 Recombinant viral switches for the control of gene expression in plants
11/26/2003EP1364033A2 Floral development genes
1 ... 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 ... 4023